Evidence map›Paper›PMID 25988124›Full record

ArticleFrontiers in nutrition2014

The Effect of BCMO1 Gene Variants on Macular Pigment Optical Density in Young Healthy Caucasians.

Zachary Kyle-Little, Andrew J Zele, C Phillip Morris, Beatrix Feigl

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Enzymology of vertebrate carotenoid oxygenases.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zachary Kyle-LittleMedical Retina Laboratory, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology , Brisbane, QLD , Australia ; School of Biomedical Sciences, Queensland University of Technology , Brisbane, QLD , Australia.
Andrew J ZeleMedical Retina Laboratory, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology , Brisbane, QLD , Australia ; School of Optometry and Vision Science, Queensland University of Technology , Brisbane, QLD , Australia.
C Phillip MorrisMedical Retina Laboratory, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology , Brisbane, QLD , Australia ; School of Biomedical Sciences, Queensland University of Technology , Brisbane, QLD , Australia.
Beatrix FeiglMedical Retina Laboratory, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology , Brisbane, QLD , Australia ; School of Biomedical Sciences, Queensland University of Technology , Brisbane, QLD , Australia ; Queensland Eye Institute , South Brisbane, QLD , Australia.
Queensland University of Technology · AUQueensland Eye Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerum lutein (L) and zeaxanthin (Z) positively correlate with macular pigment optical density (MPOD); hence, the latter is a valuable indirect tool for measuring L and Z content in the macula. L and Z have been attributed antioxidant capacity and protection from certain retinal diseases but their uptake within the eye is thought to depend on genetic, age, and environmental factors. In particular, gene variants within beta-carotene monooxygenase (BCMO1) are thought to modulate MPOD in the macula.

objectivesTo determine the effect of BCMO1 single nucleotide polymorphisms (SNPs) rs11645428, rs6420424, and rs6564851 on MPOD in a cohort of young healthy participants of Caucasian origin with normal ocular health.

designIn this cohort study, MPOD was assessed in 46 healthy participants (22 male and 24 female) with a mean age of 23.8 ± 4.0 years (range 19-33). The three SNPs, rs11645428, rs6420424, rs6564851 that have established associations with MPOD were determined using MassEXTEND (hME) Sequenom assay. One-way analysis of variance was performed on groups segregated into homozygous and heterozygous BCMO1 genotypes. Correlations between body mass index (BMI), iris color, gender, central retinal thickness (CRT), diet, and MPOD were investigated.

resultsMacular pigment optical density neither significantly varied with BCMO1 rs11645428 (F 2,41 = 0.70, p = 0.503), rs6420424 (F 2,41 = 0.21, p = 0.801) nor rs6464851 homozygous or heterozygous genotypes (F 2,41 = 0,13, p = 0.88), in this young healthy cohort. The combination of these three SNPs into triple genotypes based on plasma conversion efficiency did not affect MPOD (F 2,41 = 0.07, p = 0.9). There was a significant negative correlation with MPOD and CRT (r = -0.39, p = 0.01) but no significant correlation between BMI, iris color, gender, and MPOD.

conclusionOur results indicate that macular pigment deposition within the central retina is not dependent on BCMO1 gene variants in young healthy people. We propose that MPOD is saturated in younger persons and/or other gene variant combinations determine its deposition.

Indexed as

BCMO1luteinmaculamacular carotenoidsmacular pigment optical densityzeaxanthin

Identifiers

PMID25988124
PMCPMC4428481
OpenAlexW2145413789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.